Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

New fusion proteins designed for cancer and autoimmune diseases

March 3, 2014

U.S. researchers disclose new EGFRvIII-derived cancer vaccines

Feb. 28, 2014

ImmunoCellular Therapeutics receives orphan drug status in Europe for ICT-107 in glioblastoma

Feb. 26, 2014

OncoMed Pharmaceuticals begins third phase Ib trial of OMP-54F28

Feb. 21, 2014

Phase III ramucirumab lung cancer trial meets primary endpoint of overall survival

Feb. 20, 2014

FDA approves California Stem Cell's phase II stem trial for ovarian cancer

Feb. 19, 2014

Pierre Fabre obtains worldwide rights to immune checkpoint modulator from Aurigene

Feb. 14, 2014

Generex provides update on phase II AE-37 trial in breast cancer

Feb. 13, 2014

KaloBios begins phase II expansion portion of KB-004 study

Feb. 12, 2014

First patient receives PDS Biotechnology's PDS-0101 in phase I trial

Feb. 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...